Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Recruiting · NCT02870244 · Registry updated 2018-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 | 2018-03-12 | NCT02870244 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Loyola University | 27 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Loyola University Medical Center | Maywood | United States | 258 |